JP2024540142A5 - - Google Patents
Info
- Publication number
- JP2024540142A5 JP2024540142A5 JP2024525528A JP2024525528A JP2024540142A5 JP 2024540142 A5 JP2024540142 A5 JP 2024540142A5 JP 2024525528 A JP2024525528 A JP 2024525528A JP 2024525528 A JP2024525528 A JP 2024525528A JP 2024540142 A5 JP2024540142 A5 JP 2024540142A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273540P | 2021-10-29 | 2021-10-29 | |
| US63/273,540 | 2021-10-29 | ||
| PCT/US2022/048249 WO2023076615A1 (en) | 2021-10-29 | 2022-10-28 | Certain n-(1-cyano-2-phenylethyl)-1,4-oxazepane-2-carboxamides for treating chronic rhinosinusitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024540142A JP2024540142A (ja) | 2024-10-31 |
| JP2024540142A5 true JP2024540142A5 (https=) | 2025-11-06 |
| JPWO2023076615A5 JPWO2023076615A5 (https=) | 2025-11-06 |
Family
ID=86158626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525528A Pending JP2024540142A (ja) | 2021-10-29 | 2022-10-28 | 慢性副鼻腔炎を治療するためのある特定のｎ－（１－シアノ－２－フェニルエチル）－１，４－オキサゼパン－２－カルボキサミド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250049813A1 (https=) |
| EP (1) | EP4423071A4 (https=) |
| JP (1) | JP2024540142A (https=) |
| KR (1) | KR20240099179A (https=) |
| CN (1) | CN118159525A (https=) |
| AU (1) | AU2022376535A1 (https=) |
| CA (1) | CA3236069A1 (https=) |
| MX (1) | MX2024005126A (https=) |
| WO (1) | WO2023076615A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) | 2014-01-24 | 2018-02-24 | ||
| KR20250002710A (ko) | 2018-03-01 | 2025-01-07 | 아스트라제네카 에이비이 | (2s)-n-｛(1s)-1-시아노-2-[4-(3-메틸-2-옥소-2,3-디하이드로-1,3-벤족사졸-5-일)페닐]에틸｝-1,4-옥사제판-2-카복스아미드를포함하는 약학 조성물 |
| AU2019306532A1 (en) | 2018-07-17 | 2021-03-04 | Insmed Incorporated | Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating Lupus Nephritis |
| EP4646265A1 (en) | 2023-01-06 | 2025-11-12 | Insmed Incorporated | Novel, reversible dpp1 inhibitors and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO2699580T3 (https=) * | 2014-01-24 | 2018-02-24 | ||
| KR20250002710A (ko) * | 2018-03-01 | 2025-01-07 | 아스트라제네카 에이비이 | (2s)-n-｛(1s)-1-시아노-2-[4-(3-메틸-2-옥소-2,3-디하이드로-1,3-벤족사졸-5-일)페닐]에틸｝-1,4-옥사제판-2-카복스아미드를포함하는 약학 조성물 |
| WO2020023962A1 (en) * | 2018-07-27 | 2020-01-30 | Massachusetts Eye And Ear Infirmary | Inhibition of cystatins for the treatment of chronic rhinosinusitis |
-
2022
- 2022-10-28 US US18/704,872 patent/US20250049813A1/en active Pending
- 2022-10-28 CA CA3236069A patent/CA3236069A1/en active Pending
- 2022-10-28 AU AU2022376535A patent/AU2022376535A1/en active Pending
- 2022-10-28 EP EP22888256.9A patent/EP4423071A4/en active Pending
- 2022-10-28 MX MX2024005126A patent/MX2024005126A/es unknown
- 2022-10-28 KR KR1020247012416A patent/KR20240099179A/ko active Pending
- 2022-10-28 WO PCT/US2022/048249 patent/WO2023076615A1/en not_active Ceased
- 2022-10-28 JP JP2024525528A patent/JP2024540142A/ja active Pending
- 2022-10-28 CN CN202280071367.5A patent/CN118159525A/zh active Pending